These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19291766)

  • 21. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 23. Maternal attitudes to newborn screening for fragile X syndrome.
    Christie L; Wotton T; Bennetts B; Wiley V; Wilcken B; Rogers C; Boyle J; Turner C; Hansen J; Hunter M; Goel H; Field M
    Am J Med Genet A; 2013 Feb; 161A(2):301-11. PubMed ID: 23303663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A large-scale diagnostic program for the fragile X-syndrome among the mentally retarded. II. Implications for parents and family].
    de Vries LB; Duivenvoorden HJ; Tibben A; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1672-5. PubMed ID: 9890807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
    Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
    Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pilot Study of Fragile X Syndrome Screening in Pregnant Women and Women Planning Pregnancy: Implementation, Acceptance, Awareness, and Geographic Factors.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    J Genet Couns; 2017 Jun; 26(3):501-510. PubMed ID: 27714485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical audit of genetic testing and referral patterns for fragile X and associated conditions.
    Cotter M; Archibald AD; McClaren BJ; Burgess T; Francis D; Hills L; Martyn M; Oertel R; Slater H; Cohen J; Metcalfe SA
    Am J Med Genet A; 2016 Jun; 170(6):1439-49. PubMed ID: 26892444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Informing members of families affected by fragile X syndrome of this diagnosis].
    Carrasco M
    Rev Neurol; 2001 Oct; 33 Suppl 1():S37-41. PubMed ID: 12447818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes Towards Prenatal Genetic Counseling, Prenatal Genetic Testing, and Termination of Pregnancy among Southeast and East Asian Women in the United States.
    Tsai GJ; Cameron CA; Czerwinski JL; Mendez-Figueroa H; Peterson SK; Noblin SJ
    J Genet Couns; 2017 Oct; 26(5):1041-1058. PubMed ID: 28251433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on population screening for fragile X syndrome.
    Coffee B
    Genet Med; 2010 Jul; 12(7):411-2. PubMed ID: 20535018
    [No Abstract]   [Full Text] [Related]  

  • 35. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.
    McConkie-Rosell A; Finucane B; Cronister A; Abrams L; Bennett RL; Pettersen BJ
    J Genet Couns; 2005 Aug; 14(4):249-70. PubMed ID: 16047089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 38. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fragile X syndrome: implications of molecular genetics for the clinical syndrome.
    Rousseau F
    Eur J Clin Invest; 1994 Jan; 24(1):1-10. PubMed ID: 8187801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
    Finucane B; Lincoln S; Bailey L; Martin CL
    Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.